Chen, L., Meyers, D., Javorsky, G., Bursto, D., Lolekha, P., Lucas, M., ...
Objective: Administration of the beta-adrenergic receptor blocker carvedilol to patients with chronic heart failure leads to clinically significant benefits, including improvement in left ventricular...
Chen, L., Meyers, D., Javorsky, G., Bursto, D., Lolekha, P., Lucas, M., ...
Objective: Administration of the beta-adrenergic receptor blocker carvedilol to patients with chronic heart failure leads to clinically significant benefits, including improvement in left ventricular...
Meyers, DE, Maddicks-Law, J, Seaton, DM, Galbraith, AJ, Cuneo, RC
It has been reported that-growth hormone (GH) deficiency induced cardiomyopathy responds to growth hormone replacement therapy. We describe the case of a middle-aged male with cardiomyopathic heart...
Meyers, DE, Maddicks-Law, J, Seaton, DM, Galbraith, AJ, Cuneo, RC
It has been reported that-growth hormone (GH) deficiency induced cardiomyopathy responds to growth hormone replacement therapy. We describe the case of a middle-aged male with cardiomyopathic heart...
Sherritt, MA, Bharadwaj, M, Burrows, JM, Morrison, LE, Elliott, SL, Davis, JE, ...
Background. Adoptive transfer of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTLs) has been used to treat EBV-induced posttransplant lymphoproliferative disease (PTLD) in solid-organ...
An analysis of valve re-replacement after aortic valve replacement with biologic devices (1997)
McGiffin, DC, Galbraith, AJ, OBrien, MF, McLachlan, GJ, Naftel, DC, Adams, P, ...
Biologic valve re-replacement was examined in a series of 1343 patients who underwent aortic valve replacement at The Prince Charles Hospital, Brisbane, with a cryopreserved or 4 degrees C stored...
An analysis of valve re-replacement after aortic valve replacement with biologic devices (1997)
McGiffin, DC, Galbraith, AJ, OBrien, MF, McLachlan, GJ, Naftel, DC, Adams, P, ...
Biologic valve re-replacement was examined in a series of 1343 patients who underwent aortic valve replacement at The Prince Charles Hospital, Brisbane, with a cryopreserved or 4 degrees C stored...
Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure
Russell, FD, Meyers, D, Galbraith, AJ, Bett, N, Toth, I, Kearns, P, ...
Human urotensin-II (hU-II) is the most potent endogenous cardiostimulant identified to date. We therefore determined whether hU-II has a possible pathological role by investigating its levels in...
An analysis of valve re-replacement after aortic valve replacement with biologic devices
McGiffin, DC, Galbraith, AJ, OBrien, MF, McLachlan, GJ, Naftel, DC, Adams, P, ...
Biologic valve re-replacement was examined in a series of 1343 patients who underwent aortic valve replacement at The Prince Charles Hospital, Brisbane, with a cryopreserved or 4 degrees C stored...